Atlas Trials

A Study of LY2157299 in Participants With Pancreatic Cancer That is Advanced or Has Spread to Another Part of the Body

Clinical trial NCT02154646 · COMPLETED

Trial details

NCT number
NCT02154646
Sponsor
Eli Lilly and Company
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Pancreatic Neoplasms
Start date
2014-05-01
Primary completion
2014-09-01
Enrollment
6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.